INLB - Item 9 Labs Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
1.2200
+0.2200 (+22.00%)
At close: 3:50PM EST
Stock chart is not supported by your current browser
Previous Close1.0000
Open1.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.0000 - 1.2200
52 Week Range0.7500 - 7.1000
Volume675
Avg. Volume3,078
Market Cap74.938M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1820
Earnings DateFeb 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Item 9 Labs Corp. Closes on Nevada Asset Purchase Agreement

    PHOENIX, Feb. 20, 2020 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced.

  • GlobeNewswire

    Item 9 Labs Corp Reports Financial Results and Operational Highlights for Fiscal Year End 2019; Record Revenue of $4.9 Million

    PHOENIX, Feb. 06, 2020 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, reported.

  • GlobeNewswire

    Item 9 Labs Corp. Expands Into National CBD & Hemp Consumer Goods Market Announces Joint Venture with Third Eye Investments

    SCOTTSDALE, Ariz., Dec. 13, 2019 -- Item 9 Labs Corp. (OTC: INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis solutions for the modern consumer, today.

  • GlobeNewswire

    Item 9 Labs Corp. Appoints New CEO Andrew Bowden After Highest Revenue Month to Date

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis solutions for the modern consumer, today announced the appointment of Andrew Bowden as CEO. Bowden will continue to serve on the Company’s Board of Directors and will steer Item 9 Labs into its next phase of expansion for 2020. After the highest revenue month to date, Bowden was a natural selection to take the helm at Item 9 Labs.

  • GlobeNewswire

    Item 9 Labs Corp Becomes a Fully Reporting SEC Issuer

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced it is a Fully Reporting Company with the U.S. Securities and Exchange Commission (“SEC”) now that its Form 10 Filing became effective. The Company is now subject to the reporting requirements of the Exchange Act of 1934, as amended, including requirements to begin filing reports on Form 10-K, Form 10-Q, and Form 8-K and subjects itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules. Additionally, in an effort to provide more flexibility and liquidity for its shareholders, the Company will begin utilizing the Fast Automated Securities Transfer Program (FAST).

  • GlobeNewswire

    Item 9 Labs Corp. Reports Continued Revenue Growth in Third Quarter Results

    PHOENIX, Aug. 20, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, reported.

  • GlobeNewswire

    Item 9 Labs Corp. Launches New Vape Pen and Cartridge Line Dubbed “Cocktails”

    PHOENIX, Aug. 14, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today.

  • GlobeNewswire

    Item 9 Labs Corp. Unveils New Brand Identity Strengthening Market Share Position

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced the launch of its new corporate site and brand image. The logo and style updates strengthen the Company’s national market share positioning under one unified identity. “Item 9 Labs has expanded significantly in the past year and it was important for us to reshape our corporate branding to reflect this evolution.

  • GlobeNewswire

    Item 9 Labs Corp. Announces the Filing of Form 10 Registration Statement with the Securities and Exchange Commission

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced the filing of a Form 10 with the U.S. Securities and Exchange Commission (“SEC”). The filing provides investor detailed information on Item 9 Labs business, operations, overview of business strategy, risk factors and audited financial results. Following the effective date of the Form 10, the Company will be subject to the reporting requirements of the Exchange Act of 1934, as amended, including requirements to begin filing reports on Form 10-K, Form 10-Q, and Form 8-K and subjects itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.

  • GlobeNewswire

    Item 9 Labs Corp. Expands Marketing Team

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis health solutions for the modern consumer, today announced the expansion of its corporate marketing team with the appointment of Kyle Jennings as Vice President and the hiring of RC Giant LLC, as consulting Creative Director. “As Item 9 Labs grows, it was important for us to build a team with cannabis and mainstream marketing expertise.

  • GlobeNewswire

    Medical Marijuana Dispensary Strive Life Grand Forks Opens to North Dakota Patients May 22nd

    Strive Life is a dispensary model and subsidiary brand of Item 9 Labs Corp, a publicly traded U.S. cannabis company headquartered in Arizona. GRAND FORKS, N.D., May 21, 2019 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis health solutions for the modern consumer, today announced that medical marijuana dispensary Strive Life Grand Forks, a partner following the Company’s Strive Life business model and brand, will officially open on Wednesday, May 22nd, at 1809 13th Avenue North, in Grand Forks, North Dakota.

  • GlobeNewswire

    Item 9 Labs Corp. Reports Solid Second Quarter Results

    PHOENIX, May 17, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today.

  • GlobeNewswire

    Item 9 Labs Corp. CEO Sara Gullickson Named Top Influential Businesswoman of the Cannabis Industry

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced CEO Sara Gullickson was selected by Industry Leaders Magazine as one of the top influential businesswomen in the cannabis industry. Gullickson was recognized for her nine years as a progressive cannabis executive and recent leadership at publicly traded Item 9 Labs. In addition, Gullickson was recently selected by the Phoenix Business Journal to judge their Top 40 Under 40 Award applications.

  • GlobeNewswire

    Item 9 Labs Corp Prioritizes Sustainability at Strive Wellness of Nevada Cultivation and Processing Facility

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today announced its medical cannabis cultivation and processing facility Strive Wellness of Nevada will prioritize sustainable initiatives throughout construction. Item 9 Labs broke ground on the project in April 2019 and will be producing legal medical cannabis products under organic practices by Q4.  Located in Pahrump, Nevada, the 20,000 square-foot operation includes distribution rights. “It is incredibly rewarding to see the Nevada cultivation and processing facility come to life,” stated CEO Sara Gullickson.

  • GlobeNewswire

    Item 9 Labs Corp. Strengthens Community Relations

    PHOENIX, May 01, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, celebrated.

  • GlobeNewswire

    Item 9 Labs Corp. CEO Sara Gullickson Issues Welcome Letter to Shareholders

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, today released the following welcome letter to Item 9 shareholders from Sara Gullickson, CEO. As we enter Q2, I am taking this opportunity to introduce myself as the new Chief Executive Officer of Item 9 Labs Corp. This appointment is the culmination of many personal goals, and a position where Item 9 Labs shareholders will benefit from the skills and expertise gained throughout my nine-year cannabis career. My entrepreneurial journey began by winning multiple medical marijuana licenses across more than a dozen state markets, as well as helping to develop regulatory frameworks in the United States, Canada, Europe, and New Zealand.

  • GlobeNewswire

    Item 9 Labs Corp. Breaks Ground on Cannabis Cultivation and Processing Facility Strive Wellness of Nevada

    LAS VEGAS, April 08, 2019 -- Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leading developer and manufacturer of innovative cannabis products and.

  • GlobeNewswire

    Item 9 Labs Corp. Appoints Jeffrey Rassás as Executive Chairman of the Board

    Item 9 Labs Corp. (INLB) (“Item 9 Labs” or the “Company”), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced the appointment of Jeffrey Rassás as Executive Chairman of the Board of Directors. Rassás has resigned as Chief Strategic Officer of the Company to take on his new role as Executive Chairman.

  • GlobeNewswire

    Item 9 Labs Woman CEO and Minority Board Members Awarded Processor Provisional License for Strive Wellness of Ohio

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced CEO Sara Gullickson and African-American Advisory Board Members Donald Burton and Larry K. Lemons were awarded a processor provisional license for Strive Wellness of Ohio, LLC. The entity qualified as a disadvantaged group due to its minority-led ownership team. Item 9 Labs is in the process of negotiating a partnership agreement with Strive Wellness of Ohio to fund the management of the operation and introduce the Company’s diverse product suites.

  • GlobeNewswire

    Item 9 Labs Corp Nears Completion of Facility Expansion to More Than Double Cultivation Output Capacity

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced its Arizona expansion has neared completion. The 10,000 square-foot construction will more than double output capacity with increased cultivation manufacturing space and an infusion kitchen.